ArticleJHEP reports : innovation in hepatology2025

Serum fibrosis marker M2BPGi-based novel score predicts survival of unresectable HCC undergoing immunotherapy.

Pei-Chang Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.